Our company is collaborating with a range of partners to enable access for patients around the world
SOURCE: Merck & Co., Inc.
DESCRIPTION:
At the outset of our research efforts for COVID-19, our company made clear its commitment to make any vaccine or medicine we develop for this pandemic broadly accessible.
Here’s how we have been working to fulfill that commitment.
KEYWORDS: NYSE:MRK, Merck, global access